Human β-defensins and toll-like receptors in the upper airway

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 8, 2003, Pages 748-753

  Claeys, Sofie ^a,b   De Belder, T ^a   Holtappels, G ^a   Gevaert, P ^a   Verhasselt, B ^a   Van Cauwenberge, P ^a   Bachert, C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

defensins; Adenoids; Chronic sinusitis; Innate immunity; Lymphoid tissue; Nasal polyps; Polymerase chain reaction; Toll like receptor; Tonsils

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; BIOLOGICAL MARKER; MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ADENOID; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC SINUSITIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASAL BIOPSY; NOSE DISEASE; NOSE MUCOSA; NOSE POLYP; PARANASAL SINUS DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONSIL DISEASE; UPPER RESPIRATORY TRACT;

ADENOIDECTOMY; ADENOIDS; ADOLESCENT; BETA-DEFENSINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTROPHY; IMMUNITY, MUCOSAL; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; NASAL MUCOSA; PARANASAL SINUSES; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RESPIRATORY MUCOSA; RNA, MESSENGER; SINUSITIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TONSIL; TONSILLECTOMY;

EID: 0042672616     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00180.x     Document Type: Article

References (43)

1. WONG DT, OGRA PL. Immunology of tonsils and adenoids-an update. Int J Pediatr Otorhinolaryngol 1980;2:181-191.
2. LUND VJ. Nasal physiology: neurochemical receptors, nasal cycle and ciliary action. Allergy Asthma Proc 1996;17:179-184.
3. KALINER MA. Human nasal host defense and sinusitis. J Allergy Clin Immunol 1992;30:424-430.
4. COLE A, DEWAN P, GANZ T. Innate antimicrobial activity of nasal secretions. Inf immune 1999;67:3267-3275.
5. LEE SH, KIM JE, LIM HH. Antimicrobial defensin peptides of the human nasal mucosa. Ann Otol Rhinol laryngol 2002;111:135-141.
6. GANZ T, LEHRER RI. Defensins. Curr Opin Immunol 1994;6:584-589.
7. YANG D, CHERTOV O, OPPENHEIM JJ. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defense and adaptive immunity. CMLS 2001;58:978-989.
8. SCHIBLI DJ, HUNTER HN, AEYEV V, STARNER TD, WIENCEK JM, MCCRAY PB et al. The solution structures of human β-defensin 3 lead to better understanding of the potent bactericidal activity of HBD-3 against Staphylococcus aureus. J Biol Chem 2002;277:8279-8289.
9. SINGH PK, JIA HP, WILES K, HESSELBERTH J, LIU L, CONAWAY BAD et al. Production of β-defensin by human airway epithelia. Proc Natl Acad Sci 1998;95:14961-66.
10. HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM. Isolation and characterization of Human β defensin 3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-5713.
11. GARCIA JR, JAUMANN F, SCHULZ S, KRAUSE A, RODRIGUEZ-JIMENEZ J, FORSSMANN U et al. Identification of a novel multifunctional beta-defensin (HBD-3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001;306:257-264.
12. HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM. A peptide antibiotic from human skin. Nature 1997;387:861-862.
13. LUI L, WANG L, JIA HP, ZHAO C, HENG HHQ, SXHUTTE BC et al. Structure and mapping of the human β-defensin gene and its expression at sites of inflammation. Gene 1998;222:237-244.
14. BECKER MN, DIAMOND G, VERGHESE MW, RANDELL SH. CDI4-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000;275:29731-29736.
15. JIA HP, SCHUTTE BC, SCHUDY A, LINZMEIER R, GUTHMILLER JM, JOHNSON GK et al. Discovery of a new human beta defensins using genomics-based approach. Gene 2001;263:211-218.
16. SCHUTTE BC, MC CRAY PB Jr. β-defensin in lung host defense. Annu Rev Physiol 2002;64:709-748.
17. ALI RS, FALCONER A, IKRAM M, BISSETT CA, CERIO R, QUINN AG. Expression of peptide antibiotic human β defensin-1 and human β defensin-2 in normal human skin. J Invest Dermatol 2001;117:106-111.
18. SCHRODER JM, HARDER J. Human beta-defensin-2. Int J Biochem Cell Biol 1999;31:645-651.
19. CLAEYS S, CUVELIER C, QUATACKER J, VAN CAUWENEBRGE P. Ultrastructural investigation of M-cells and lymphoepithelial contacts in naso-pharyngeal associated lymphoid tissue (NALT). Acta Otolaryngol Suppl 1996;523:40-42.
20. KRAEHENBUHL JP, NEUTRA MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000;16:301-332.
21. NEUTRA MR, MANTIS NJ, KRAEHENBUHL JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001;2:1004-1009.
22. UEHARA A, SUGAWARA S, TAKADA H. Priming of human oral epithelial cells by interferon-γ to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptoglycans. J Med Microbiol 2002;51:626-634.
23. ASAI Y, OHYAMA Y, GEN K, OGAWA T. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun 2001;69:7387-7395.
24. KRUTZIK SR, SIELING PA, MODLIN RL. The role of toll-like receptors in host defense against microbial infection. Curr Opin Immunol 2001;13:104-108.
25. CARIO E, ROSENBERG IM, BRANDWEIN SL, BECK PL, REINECKER HC, PODOLSKY DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol 2000;164:966-972.
26. CARIO E, PODOLSKY DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR 3) and TLR 4 in inflammatory bowel disease. Infect Immunol 2000;68:7010-7017.
27. WANG X, MOSER C, LOUBOUTIN JP, LYSENKO AS, WEINER DJ, WEISER JN, WILSON JM. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 2002;168:810-815.
28. HARDER J, MEYER-HOFFERT U, TERAN LM, SCHWICHTENBERG I, BARTELS J, MAUNE S, SCHRODER JM. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000;22:714-721.
29. HIRATSUKA T, NAKAZATO M, DATE Y, ASHITANI J, MINERNTSU T, CHINO N, MATSUKURA S. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998;249:943-947.
30. ASHITTANI J, MUKAE H, HIRATSUKA T, NAKAZATO M, KUMAMOTO K, MATSUKURA S. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium Avium-intracellular infection. Chest 2001;119:1131-1137.
31. WEISE JB, MEYER JE, HELMER H, WITTROCK H, MAUNE. A newly discovered function of palatine tonsils in immune defence: the expression of defensins. Otolaryngol Pol 2002;56:409-413.
32. BROOK I, YOCUM P, SHAH K. Surface versus core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA 1980;244:1696-1698.
33. MEDZHITOV R, JANEWAY CA Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000;173:89-97.
34. JANEWAY CA Jr, MEDZHITOV R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
35. LIEN E, INGALLS RR. Toll-like receptors. Crit Care Med 2002;30:S1-S11.
36. AKIRA S, TAKEDA K, KAISHO T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
37. SCHWANDNER R, DZIARSKI R, WESCHE H, ROTHE M, KIRSCHNING CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-17409.
38. LAFLAMME N, RIVEST S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J 2001;15:155-163.
39. SHUTO T, XU H, WANG B. Activation of NF-κβ by nontypeable Hemophilus influenza is mediated by toll-like receptor 2-TAK1-dependent NIK-IKKα/β-1κBα and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. PNAS 2001;98:8774-8779.
40. DIAMOND G, RUSSELL JP, BEVINS CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci 1996;93:5156-5160.
41. KAWAI K, SHIMURA H, MINAGAWA M, ITO A, TOMIYAMA K, ITO M. Expression of functional toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002;30:185-194.
42. BEUTLER E, GELBART T, WEST C. Synergy between TLR-2 and TLR-4: a safety mechanism. Blood Cells Mol Dis 2001;27:728-730.
43. HAUSMANN M, KIESSLING S, MESTERMANN S, ROGLER G. Toll-like receptors 2 and 4 are upregulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000.